It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
G-quadruplexes (G4) are non-canonical secondary structures consisting in stacked tetrads of hydrogen-bonded guanines bases. An essential feature of G4 is their intrinsic polymorphic nature, which is characterized by the equilibrium between several conformations (also called topologies) and the presence of different types of loops with variable lengths. In cells, G4 functions rely on protein or enzymatic factors that recognize and promote or resolve these structures. In order to characterize new G4-dependent mechanisms, extensive researches aimed at identifying new G4 binding proteins. Using G-rich single-stranded oligonucleotides that adopt non-controlled G4 conformations, a large number of G4-binding proteins have been identified in vitro, but their specificity towards G4 topology remained unknown. Constrained G4 structures are biomolecular objects based on the use of a rigid cyclic peptide scaffold as a template for directing the intramolecular assembly of the anchored oligonucleotides into a single and stabilized G4 topology. Here, using various constrained RNA or DNA G4 as baits in human cell extracts, we establish the topology preference of several well-known G4-interacting factors. Moreover, we identify new G4-interacting proteins such as the NELF complex involved in the RNA-Pol II pausing mechanism, and we show that it impacts the clastogenic effect of the G4-ligand pyridostatin.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Université de Toulouse, CNRS, UPS, Institut de Pharmacologie et Biologie Structurale, IPBS, Toulouse, France (GRID:grid.15781.3a) (ISNI:0000 0001 0723 035X); Equipe Labellisée Ligue Contre Le Cancer 2018, Toulouse, France (GRID:grid.15781.3a)
2 Université Grenoble Alpes, Département de Chimie Moléculaire, UMR CNRS 5250, Grenoble, France (GRID:grid.450308.a) (ISNI:0000 0004 0369 268X)
3 Université Grenoble Alpes, CEA, INSERM, IRIG, BGE, Grenoble, France (GRID:grid.450308.a) (ISNI:0000 0004 0369 268X)
4 Structure et Instabilité des Génomes, Muséum National d’Histoire Naturelle, CNRS, INSERM, Paris, France (GRID:grid.503191.f) (ISNI:0000 0001 0143 5055)